| Similar Articles |
|---|
 |
Wired
November 17, 2007
Thomas Goetz |
23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics A much-anticipated Silicon Valley startup called 23andMe offers a thorough tour of your genealogy, tracing your DNA back through the eons.   |
Managed Care
May 2001
Michael D. Dalzell |
Powerful Opportunities For Good and Greed Genetic advances could spawn incredible improvements in health care. Given public demand, they also pose what may be unmanageable issues of resource use... |
Fast Company
December 1, 2007
Amanda Bower |
Are There Holes In My Genes? A new industry promises to gauge your genetic risk of getting diseases like cancer. Its investors, including John Doerr's Kleiner Perkins and Mark Kvamme's Sequoia Capital, have bet millions that consumers will buy it. Here, the author takes a test. |
Managed Care
November 2006
Maureen Glabman |
Genetic Testing: Major Opportunity, Major Problems Whether a person is likely to develop diabetes, cancer, schizophrenia, or stroke will be reasonably well predicted, and tests can also determine whether a patient will respond to a given therapy. That's the good part. |
IEEE Spectrum
March 2013
Eliza Strickland |
The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine |
Wired
November 2002
David Ewing Duncan |
DNA as Destiny DNA is the book of life. It's also the book of death. In the future we'll all be read cover to cover. Here's what it's like to take the world's first top-to-bottom gene scan. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
Managed Care
May 2005
Martin Sipkoff |
Predictive Modeling & Genomics: Marriage of Promise and Risk Integration of predictive modeling and genomic tools means improved technology, enhanced databases, and appropriate legal guidance. |
Fast Company
Elizabeth Segran |
23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer. |
Chemistry World
February 25, 2015
Rebecca Trager |
US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests. |
Fast Company
September 2000
John Ellis |
The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning. |
The Motley Fool
May 28, 2010
Brian Orelli |
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. |
BusinessWeek
September 5, 2005
Capell & Arndt |
Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx. |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Salon.com
August 11, 2000
Jackie Stevens |
Does capitalism make you sick? Gene studies are sexy and well funded, but they can buttress racial thinking and distract the public from the socioeconomic roots of disease. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
AskMen.com
Jacob Franek |
Genetic Testing Every day the prospect of individualized genetic testing is slowly becoming commonplace, and certain questions about genetic testing are apparent: What kinds of tests are available? Where can I get them? How accurate are they? And what are the costs? |
BusinessWeek
January 21, 2010
Rich Jaroslovsky |
Web DNA Tests Offer Ease and Enlightenment A comparison of the often entertaining services of Navigenics, 23andMe, and deCODEme. |
Fast Company
David Lumb |
The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk. |
Entrepreneur
February 2009
Dennis Romero |
DNA Testing: A Growth Market The barriers to entry are daunting, but the DNA market provides opportunities. |
HHMI Bulletin
May 2012
Sarah C. P. Williams |
Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies. |
Fast Company
November 2013
Elizabeth Murphy |
To Know You Is To Really Know You A deeper look at the makeup of genetic testing firm 23andme's customers and what their DNA reveals. |
BusinessWeek
November 7, 2005
Catherine Arnst |
How Likely Are You To Get Sick? A new DNA database could gauge your risk for disease. |
Bio-IT World
November 14, 2003
Kathy Ordonez |
Targeted Medicine via Molecular Diagnostics Using diagnostics to select and deselect target populations for drug therapy will enable life scientists to make more effective medicines. |
Managed Care
August 2004
Thomas Morrow |
10,000 Cells on a Chip Signal Start of New Era of Diagnosis Diseases will soon be defined by biochemical pathways and genetic interactions. Biochips may identify patients likely to respond to therapeutic agents. All of this is a big deal for health plans. |
The Motley Fool
November 30, 2010
Brian Orelli |
Better Buy: Exact Sciences or Sequenom? A battle of the diagnostic test makers. |
AskMen.com
October 30, 2013
Michelle Magnan |
The Difference Between Usain Bolt And You: The point that David Epstein explores at length in The Sports Gene, is that no two people respond to sports training the same way, because no two genomes are the same. |
The Motley Fool
August 24, 2007
Brian Orelli |
Take Your Medicine; Earn Your Profits Personalized medicine offers investment ideas. Let's take a look at what this new catchphrase in the medical community actually means, and how investors can benefit from it. |
Fast Company
John Paul Titlow |
23andMe Wants To Turn Your DNA Data Into Lucrative New Drugs 23andMe's original business model may have been thwarted by the feds, but that isn't stopping the company from trying new ways to generate revenue. Its latest idea could be a lucrative one: invent new drugs. |
Chemistry World
June 6, 2007
Simon Hadlington |
Large-Scale Gene Scanning for Common Diseases A multi-center genome scanning project that has analyzed half a million genetic markers in thousands of healthy people and people with a range of common diseases has revealed previously unknown genetic variants of the diseases. |
Bio-IT World
September 9, 2002
Kevin Davies |
The Debate Over Race Relations Are self-identified labels of race useful in large-scale population genetic studies? A provocative commentary from a leading Stanford University geneticist has fuelled controversy. |
BusinessWeek
October 23, 2008
John Carey |
Reading the Entire Genetic Code Pioneers such as 23andMe and Navigenics use snips of genes to make medical predictions. Now new tools from more start-ups are on the horizon. |
BusinessWeek
May 9, 2005
John Carey |
Dr. Francis S. Collins: On The Trail Of Disease Genes Collins is leading the search for DNA variations that can result in illnesses. |
Salon.com
May 25, 2002
Katharine Mieszkowski |
Our shiny happy clone future Procreation without sex, smarter babies and the right to choose the sexual orientation of your kids -- it's all good, says scientist Gregory Stock... |
IEEE Spectrum
March 2013
Susan Hassler |
Genome to Go It's already possible to have your own genome sequenced. But personalized medicine based on sequencing still has a way to go |
Fast Company
Pavithra Mohan |
App Used 23andMe's DNA Database To Block People From Sites Based On Race And Gender Personal genetics company 23andMe discovered that a programmer had used its open API to create a screening mechanism for websites -- which could effectively block people by race, sex, and ancestry. |
The Motley Fool
August 12, 2009
Brian Orelli |
The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing. |
Fast Company
November 2013
Robert Safian |
A Code to Live By In an age of flux, there are so many emerging technologies and newly founded companies, it is near-impossible to predict which ones will have staying power. Our approach: Focus on those areas that combine cross-industry impact and human appeal. |
Fast Company
David Lumb |
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. |
The Motley Fool
June 14, 2010
Bruce Bigelow |
Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval. |
Chemistry World
March 23, 2015
Andrew Turley |
23andMe jumps into drug R&D 23andMe plans to create a therapeutics group that will search for new leads using its database as a research platform. |
Fast Company
David Lumb |
Apple Is Planning iPhone Apps That Let You Share Your DNA Down the line, these apps could let users share their DNA data just like iPhone users share their locations now, says MIT Technology Review. |
IEEE Spectrum
March 2011
Lucks & Arkin |
Synthetic Biology's Hunt for the Genetic Transistor How genetic circuits will unlock the true potential of bioengineering |
Salon.com
June 26, 2000
Ralph Brave |
The great gene race A tiny private company and the giant public genome project jointly crossed the finish line. But the upstart really won. |
Wired
Brendan I. Koerner |
Mr. Know-It-All: Disclosing DNA, Enrolling Friends in Rehab, Protecting Peepers on a PDA Telling your loved ones about DNA results... Online rehab programs like eGetgoing... Is watching movies on a PDA bad for your eyes?... |
Managed Care
April 2005
Michael Levin-Epstein |
Time To Decipher Legislation's DNA Health plans have much at stake as Congress moves to lay down the do's and don'ts about use of info gathered via genetic testing. |
The Motley Fool
May 30, 2007
Rick Aristotle Munarriz |
Warren Buffett Is No Parrothead Jimmy Buffett and Warren Buffett aren't related. Solving the Buffett mystery illustrates how a stake in 23andMe is a good fit in Google's portfolio. Investors, take note. |
Investment Advisor
January 2008
James J. Green |
Someting Old and New Will financial advisors also need to be genetic counselors for their clients in the near future? |
Fast Company
November 2013 |
Behind The Scenes Of The Ad Campaign For 23andMe's $99 DNA Test When conceptualizing the first commercial for 23andMe, ad agency Arnold had a challenge: destigmatize genetic testing while communicating what the company actually does. |
Wired
November 17, 2007
Thomas Goetz |
What My Genome Says About Me The gene variations that lead to the most popular diseases in the U.S. |
